AC
IMGN

Avestar Capital’s Immunogen Inc IMGN Stock Holding History

Avestar Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,849
Closed -$1K – 888
2019
Q2 		$1K Buy
2,849
+849
+42% +$2.01K ﹤0.01% 823
2019
Q1 		$1K Buy
2,000
+477
+31% +$2.07K ﹤0.01% 811
2018
Q4 		$1K Buy
1,523
+196
+15% +$1.19K ﹤0.01% 798
2018
Q3 		$1K Buy
1,327
+24
+2% +$231 ﹤0.01% 785
2018
Q2 		$1K Buy
1,303
+181
+16% +$1.91K ﹤0.01% 836
2018
Q1 		$0 Buy
1,122
+62
+6% +$612 ﹤0.01% 969
2017
Q4 		$0 Buy
+1,060
New +$6.54K ﹤0.01% 792

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Avestar Capital's IMGN Position: Q3 2019 in Review

Avestar Capital sold out of Immunogen Inc (IMGN) in Q3 2019, closing a stake of 2,849 shares — an estimated $1K sold.

Avestar Capital first reported a position in IMGN in Q4 2017 and held it in 7 quarters. The position peaked at $1K in Q2 2019. 189 funds tracked by Wall St. Rank hold IMGN as of Q3 2019.

  • Avestar Capital reported no remaining Immunogen Inc position as of Q3 2019 after selling out during the quarter.
  • Avestar Capital sold 2,849 Immunogen Inc shares in Q3 2019, an estimated $1K.
  • Avestar Capital first reported a position in Immunogen Inc in Q4 2017 and held it in 7 quarters.
  • Avestar Capital's Immunogen Inc position peaked at $1K in Q2 2019.
  • 189 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.